AGP Executive Report

Ebola Emergency Escalates in DR Congo: WHO has raised the outbreak risk in the Democratic Republic of the Congo to “very high” as Bunia authorities ban large funeral wakes to slow spread; confirmed cases and deaths are rising, with hundreds more suspected and no vaccine available for this strain. UNRWA Under Pressure: UNRWA’s commissioner-general warns the agency is close to becoming unviable amid political pressure, funding strain, and Gaza sidelining—raising questions about what comes next for Palestinian health and education services. New Cancer Option in the US: FDA approval of AstraZeneca/Daiichi Sankyo’s Datroway expands first-line treatment for metastatic triple-negative breast cancer patients who can’t use PD-1/PD-L1 inhibitors. Swiss Health Signal: A nationwide BMI survey suggests childhood obesity is stabilising, with improvements mainly among younger pupils but persistent social gaps. Swiss Watch in the News: Switzerland’s population cap debate keeps resurfacing as housing pressure fuels renewed political momentum.

Ebola Escalation: WHO says the Congo outbreak risk is now “very high” locally, with 82 confirmed cases and 177 suspected deaths as violence and weak resources slow the response—while Canada has tightened airport screening and added extra questions for travellers. OCD Breakthrough: A new study links serotonin to faster updating of rigid beliefs in OCD, using an escitalopram placebo-controlled trial and a “changing seasons” game—pointing to more targeted drug-plus-therapy approaches. Swiss Health Tech: A Swiss report finds 95% of QA/QC labs use digital tools, but only 1 in 5 are truly digital, with Excel still doing much of the work. Infant Safety Scrutiny: Greenpeace renews pressure on Nestlé and Danone after finding microplastics in baby food pouches. Workforce Pressure in Switzerland: Adecco warns a 10-million population cap could restrict access to skilled foreign workers and hit growth.

Steatotic Liver Disease push in Geneva: Global Liver Institute and Egypt’s health ministry convened a WHA79 policy event to turn the new SLD resolution into action, with ministers and clinicians backing whole-of-government prevention, earlier detection in primary care, and progress toward UHC and NCD targets. Dementia benefits warning (UK): Zurich says many people with dementia may be missing DWP payments because benefits aren’t automatic and rules are hard to navigate—potentially losing £1,000–£5,000 a year. Biosimilars deal (LATAM): Polpharma Biologics signed a licensing agreement with Argentina’s Tuteur for an autoimmune biosimilar across Latin America (excluding Brazil), keeping development and manufacturing with Polpharma. Swiss health policy backdrop: Switzerland’s housing squeeze debate continues to shape public pressure, while broader health-system themes—workforce strain and mental health costs—remain a growing insurer concern. Local safety and care: A Swiss “suicide pod” case is under scrutiny after reports of unexplained neck marks, keeping attention on end-of-life safeguards.

FISU Planning Push: A Lausanne-led FISU team just wrapped a 15-day North Carolina site visit to map venues and operations for the 2029 World University Games, with sport technical committee chairs from 15 countries running inspections and seminars. Travel Demand vs. Cost: A new Allianz Partners survey finds 74% of people still plan summer leisure trips, but price anxiety is driving cuts—especially in non-essential spending—with domestic travel rising as the budget-friendly option. Geneva Public Access: UN Geneva’s Portail des Nations visitors’ centre is set to open in June 2026, aiming to make multilateral work on public health, climate, innovation and human rights more accessible. Ebola Warning: WHO and partners say the latest DRC Ebola figures likely represent only the visible “tip,” with wider spread and undercounting feared. Swiss Health Tech & Pharma: Distalmotion reports growing US adoption of its outpatient robotic surgery system, while Roche’s licensing deal clears the way for generic baloxavir in 129 low- and middle-income countries. Cancer Care Spotlight: Jamaica is set to expand public cancer screening and treatment capacity with IAEA support, including breast cancer mammography upgrades.

AI in Care Access: King Faisal Specialist Hospital (KFSH) says AI should act as a “force multiplier” to expand patient access—helping with radiology triage, monitoring, and hospital capacity—without replacing clinicians. Ebola Alarm in Central Africa: WHO is warning that the current DRC outbreak (Bundibugyo strain) is spreading fast, with no vaccine or drug and a high fatality rate; officials stress surveillance and contact tracing must scale up. Brain-Tech Funding: Switzerland-headquartered Neurosoft Bioelectronics raised $7.5M seed funding to advance minimally invasive brain-computer interfaces for neurological conditions like tinnitus and epilepsy. Public Health Watchdog: A Bern-based group warns that “too many health checks” can backfire—driving false positives, overdiagnosis, and unnecessary treatment. Swiss Tech & Privacy: A Swiss smart-city surveillance critique argues democracies can still lose control when monitoring is enabled by private tech. Breast Cancer Update: Vanessa Trump disclosed a breast cancer diagnosis, days after Tiger Woods’ rehab-related news.

BCI Funding Boost: Geneva-based Neurosoft Bioelectronics just closed an oversubscribed $7.5M seed round to push its minimally invasive brain-computer interface, with plans to expand from neurological conditions toward broader human-machine communication. Orphan Drug Milestone: Swissmedic granted orphan status to Belite Bio’s tinlarebant for Stargardt disease type 1, after positive phase 3 DRAGON results—positioning it for possible first-in-world approval. Ebola Alarm in Congo: WHO says the rare Bundibugyo Ebola outbreak in DR Congo likely started months ago; risk is low globally, but on the ground teams report delays, underprotection, and fast spread with no vaccine or approved treatment. Health System Pressure: Switzerland’s Lonza Visp site continues ramp-up toward mid-2026 commercial operations for key drug manufacturing capacity. Cancer Support Tool: NCCN updated its Distress Thermometer screening resource in 70+ languages to help cancer teams spot and address patient distress early.

Hantavirus Watch in Switzerland: A crew member from the MV Hondius has been flown to canton Aargau and placed in a 42-day quarantine as a contact, with no symptoms and an initial negative test—if a follow-up test at Aarau Cantonal Hospital is also negative, he can finish quarantine at home. Global Health Diplomacy: Malaysia and Singapore used a Geneva meeting to align food labelling and speed medical-device access, while expanding cross-border health tourism and referral pathways. Mental Health R&D: Synendos Therapeutics has started dosing a Phase 2 trial for generalized anxiety disorder in Switzerland-linked research with King’s College London, aiming for early 2027 results. Infant Formula Scrutiny: Nestlé and Danone face fresh questions in Europe over alleged delays tied to cereulide contamination and recalls. Swiss Spotlight: Switzerland topped US News & World Report’s 2026 “Best Countries” ranking, with India at 63rd.

Infant Formula Fallout: Nestlé and Danone face fresh scrutiny after French, Belgian and Swiss media allege delays in notifying regulators and recalling products linked to cereulide contamination, with Nestlé saying it acted transparently and followed a strict traceability process. Early Detection in Focus: A Japan community trial using nurse-led ultrasound screening for hip dysplasia found suspected cases in 8.7% of infants, including many without risk factors—pushing the idea that wider screening could prevent late diagnoses. WHO Diplomacy Under Strain: Taiwan’s bid to join the World Health Assembly as an observer was rejected again under the “One China” principle, while WHO leaders continue to grapple with Ebola and funding pressure. Swiss Health Tech & Pharma Moves: Swiss barox appoints a North America business development director; and Swiss firms report ongoing clinical and radiopharma updates ahead of major meetings like ASCO and SNMMI. Global Health Funding Pressure: A new report highlights how donor cuts are disrupting programmes worldwide as delegates meet in Geneva.

Biotech Push in the US: Bio-Thera’s golimumab biosimilar BAT2506 has won FDA approval, adding new options for rheumatoid arthritis (and also ulcerative colitis in the subcutaneous form). Allergy Trial Progress (Switzerland-linked): Mabylon reports positive Phase Ia safety for MY006 in a first-in-human peanut allergy study and starts Phase Ib dosing for peanut-allergic participants, with its work also advancing a tree pollen program toward clinic. Transplant Access Deal: SERB will buy European and MENA rights to Idefirix® (imlifidase) for €115m, aiming to expand desensitisation before kidney transplants for highly sensitised patients—Switzerland included in the territory. Swiss Health Policy Spotlight: At the World Health Assembly opening in Geneva, WHO chief Tedros warned that Ebola and hantavirus are unfolding amid “dangerous and divisive” times, while WHO says finances have stabilised after restructuring. Local Innovation: Swiss Innovation Prize 2026 finalists include Mindanao State University-Iligan Institute of Technology teams working on turning industrial waste into construction materials.

World Health Assembly in Geneva: WHO members rejected a proposal to invite Taiwan to participate in the annual assembly for the 10th straight year, as China pushed back and warned it would block Taiwan’s involvement. Ghana health financing shift: President John Dramani Mahama says Ghana is on track to exit Gavi vaccine support by 2030 and move toward becoming a donor, alongside NHIS expansion and a major funding boost. Hantavirus & cruise scrutiny: WHO is meeting amid Ebola and hantavirus concerns tied to a Dutch cruise outbreak, with officials stressing the general public risk remains low while monitoring continues. Swiss-linked health news: Swissmedic granted orphan drug status in Switzerland for Belite Bio’s tinlarebant in Stargardt disease. Cancer care tech: An AI avatar “pre-consult” approach reduced stress for radiation patients before meeting clinicians. Local policy watch: Switzerland’s health minister is concerned about Italy’s proposed health tax for cross-border workers in Ticino.

Online Safety Push at WHA: Meghan Markle used Geneva’s Lost Screen Memorial to call children’s online harm a “public health issue,” warning that attention-grabbing algorithms can steer kids toward eating disorders and other abuse. Global Health Diplomacy: China hit back at Taiwan’s foreign minister attending WHO-linked events in Switzerland, while Qatar confirmed its WHA participation and agenda on prevention, UHC, and AMR. Infectious Disease Watch: UKHSA updated the hantavirus cruise outbreak response, with asymptomatic contacts from St Helena and Ascension Island being monitored at Arrowe Park. Cancer Care Tech: An international trial reports AI can generate radiotherapy plans to international best practice faster, helping more patients get timely treatment, with targeted radiotherapy showing longer progression-free survival in metastatic breast cancer. Swiss Health Politics: Swiss medics oppose the SVP’s 10-million population cap, warning it could worsen staffing shortages ahead of the June 14 vote.

Online Safety at WHA: Meghan Markle used a Geneva memorial for children harmed by digital platforms to call children’s online safety a “public health issue,” warning that attention-driven systems and AI can “accelerate and amplify” harm across borders. Suicide Prevention in Tech: Global health leaders also pushed for suicide-prevention safeguards to be built into AI chatbots and online safety policy, framing it as public health—not just tech governance. Ebola Escalation: WHO declared Ebola in the DRC a public health emergency of international concern (PHEIC), citing the Bundibugyo variant and no vaccine for it, with cases and suspected infections rising in Ituri. Cancer Care Updates: ESTRO 2026 research highlighted targeted radiotherapy that may delay progression in metastatic breast cancer, and prostate radiotherapy that could cut sessions from five to two with minimal added side effects. Switzerland Angle: Switzerland is hosting key global health moments this week, including the WHA-linked Geneva events tied to child online safety.

Ebola Alert: WHO has declared the DRC’s Bundibugyo Ebola outbreak a public health emergency of international concern, reporting 80 deaths and 246 suspected cases in Ituri—while Kenya is now on watch after Uganda recorded cross-border cases including deaths in Kampala. Luxury Watch Chaos: Audemars Piguet x Swatch “Royal Pop” launched with crowds and store disruptions across cities, and the frenzy is now driving steep online resales. Hantavirus on Cruise Ships: Cruise travel demand looks “undimmed” despite hantavirus and norovirus outbreaks, even as new attention grows around how long hantavirus may persist in semen and what that could mean for transmission risk. Swiss Health Policy: In the US, CarolinaEast Medical Center is set to leave major Medicare Advantage networks from July 1, citing payment denials and reimbursement delays as unsustainable. Cancer Care Update: Real-world data on extended adjuvant neratinib in HER2+/HR+ early breast cancer shows high adherence and no new safety signals.

WHO in Geneva: A senior Zimbabwean health official is chairing the WHO Executive Board’s Programme Budget and Administration Committee meetings (12–15 May) ahead of the 79th World Health Assembly, keeping a close eye on global health finances and staffing. Cancer care update: The FDA has approved Enhertu for two new HER2-positive early breast cancer indications—both neoadjuvant (with THP) and adjuvant for patients with residual invasive disease—based on DESTINY-Breast11 and DESTINY-Breast05. Switzerland opens dark history files: Switzerland says it will finally release long-sealed files on Nazi doctor Josef Mengele, the “Angel of Death,” after years of historian pressure. Public health risk watch: Swiss authorities warn of high risk of African swine fever spreading into the country. Clinical nutrition evidence: A large UK Biobank study links higher vitamin K1 intake with lower COPD risk and better lung function, especially among smokers and people exposed to workplace irritants. Health system pressure (US): CarolinaEast Medical Center in North Carolina will drop out-of-network status for some Medicare Advantage plans from 1 July, citing payment denials and reimbursement delays.

Health Policy & Access: In North Carolina, CarolinaEast Medical Center says it will leave in-network status for UnitedHealthcare and Blue Cross Blue Shield Medicare Advantage plans from July 1, citing “payment policies, denials and reimbursement delays” that became financially unsustainable. Cancer Care: The US FDA approved AstraZeneca/Daiichi Sankyo’s ENHERTU for two new uses in HER2-positive early breast cancer—neoadjuvant and adjuvant settings. Global Health Leadership: WHO-hosted Partnership for Maternal, Newborn and Child Health appoints former New Zealand PM Helen Clark’s successor, Monica Geingos, as board chair. Infectious Disease Watch: Swiss authorities warn African swine fever risk remains high, urging travelers not to bring pork/wild boar meat and noting wild boar testing so far is negative. Switzerland in the spotlight: Switzerland has agreed to declassify Nazi Josef Mengele files, after historians pushed for access.

Hantavirus Watch: WHO says the suspected Andes hantavirus cluster on a cruise ship is “not the start of a COVID pandemic,” stressing it spreads via close, intimate contact and that onboard precautions are meant to stop onward spread. Sex-Transmission Concern: A Swiss Spiez Laboratory study reports hantavirus genetic material can persist in semen up to 71 months after infection, raising questions about whether sexual transmission is possible long after recovery. Mental Health in War Zones: WHO warns Ukraine’s war-driven mental health crisis could echo for generations, citing anxiety/stress and worsening health and higher hospital admissions for stroke and heart attacks. Drug Pricing Pressure: A new analysis argues the White House’s “Most-Favored Nation” approach is unlikely to deliver real savings and may rely on misleading claims. Swiss Health Policy Context: Switzerland’s role in global health diplomacy continues, with WHO-related events drawing high-profile attention in Geneva.